JPH05339153A - アミノアルコールとポリカルボン酸とのｎ−アシル誘導体を含む医薬組成物 - Google Patents

アミノアルコールとポリカルボン酸とのｎ−アシル誘導体を含む医薬組成物

Info

Publication number
JPH05339153A
JPH05339153A JP4361556A JP36155692A JPH05339153A JP H05339153 A JPH05339153 A JP H05339153A JP 4361556 A JP4361556 A JP 4361556A JP 36155692 A JP36155692 A JP 36155692A JP H05339153 A JPH05339153 A JP H05339153A
Authority
JP
Japan
Prior art keywords
acid
pharmaceutical composition
composition according
group
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4361556A
Other languages
English (en)
Japanese (ja)
Inventor
Valle Francesco Della
デッラ ヴァッレ フランチェスコ
Silvana Lorenzi
ロレンツィ スィルヴァナ
Gabriele Marcolongo
マルコロンゴ ガブリエレ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RAIFUGURUUPU SpA
LifeGroup SpA
Original Assignee
RAIFUGURUUPU SpA
LifeGroup SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RAIFUGURUUPU SpA, LifeGroup SpA filed Critical RAIFUGURUUPU SpA
Publication of JPH05339153A publication Critical patent/JPH05339153A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
JP4361556A 1991-12-31 1992-12-28 アミノアルコールとポリカルボン酸とのｎ−アシル誘導体を含む医薬組成物 Pending JPH05339153A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI913509A IT1252866B (it) 1991-12-31 1991-12-31 N-acilderivati di aminoalcooli con acidi policarbossilici atti alla modulazione dei mastociti nei processi infiammatori su base neuroimmunogenica
IT91A003509 1991-12-31

Publications (1)

Publication Number Publication Date
JPH05339153A true JPH05339153A (ja) 1993-12-21

Family

ID=11361453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4361556A Pending JPH05339153A (ja) 1991-12-31 1992-12-28 アミノアルコールとポリカルボン酸とのｎ−アシル誘導体を含む医薬組成物

Country Status (4)

Country Link
EP (1) EP0550008A3 (und)
JP (1) JPH05339153A (und)
CA (1) CA2086441A1 (und)
IT (1) IT1252866B (und)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037650A1 (fr) * 1996-04-05 1997-10-16 Santen Pharmaceutical Co., Ltd. Medicaments contre les maladies retiniennes
JP2002284751A (ja) * 2001-03-28 2002-10-03 Nagase Kasei Kogyo Kk 新規化合物ならびにそれを用いた吸水性樹脂用架橋剤および吸水性樹脂
JP2007262068A (ja) * 2006-03-28 2007-10-11 Epitech Group Srl 免疫系の一般的反応により引き起こされる病態の治療のための医薬組成物
JP2009545623A (ja) * 2006-08-04 2009-12-24 マリノメド・ビオテヒノロギー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング エスシンの使用
JP2012102097A (ja) * 2010-11-08 2012-05-31 Epitech Group Srl Ｎ−パルミトイル−バニルアミドを含有する局所使用用薬理学的製剤
JP2016028022A (ja) * 2014-07-08 2016-02-25 エピテック・グループ・ソチエタ・ア・レスポンサビリタ・リミタータＥＰＩＴＥＣＨ ＧＲＯＵＰ Ｓ．ｒ．ｌ． 上皮機能障害の処置におけるアデルミドロールの使用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271623B (it) * 1994-03-21 1997-06-04 Lifegroup Spa N-acilderivati di aminoalcoli con acidi monocarbossilici e bicarbossilici con attivita' neuroprotettiva nelle patologie neurologiche correlate ad eccitotossicita'
US5696099A (en) * 1994-04-18 1997-12-09 Lifegroup S.P.A. Topical preparations for the treatment of acne and acneiform dermatitis
IT1271266B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
EP0812588B1 (en) * 1995-12-28 2004-10-13 Mitsubishi Pharma Corporation Pharmaceutical external preparations for topical administration comprising 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for the treatment of diseases induced from immune disorder
ATE516264T1 (de) 1999-07-07 2011-07-15 Innovet Italia Srl Kovalente derivate von mono- und dicarbonsäuren- alkanolamiden, die auf den cb2 cannabinoiden rezeptor wirken
ES2239453T3 (es) * 1999-08-06 2005-09-16 Innovet Italia S.R.L. Composiciones farmaceuticas que contienen n-palmitoiletanolamida y uso de ellas en el campo veterinario.
CN104491045A (zh) * 2014-12-11 2015-04-08 李学存 骨伤舒筋活络膏及制备方法
ITUB20154849A1 (it) * 2015-10-30 2017-04-30 Epitech Group S P A ADELMIDROL PER L'USO NELLE PATOLOGIE CARATTERIZZATE DA INSUFFICIENTE AGONISMO DEL RECETTORE PPAR-gamma

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037650A1 (fr) * 1996-04-05 1997-10-16 Santen Pharmaceutical Co., Ltd. Medicaments contre les maladies retiniennes
JP2002284751A (ja) * 2001-03-28 2002-10-03 Nagase Kasei Kogyo Kk 新規化合物ならびにそれを用いた吸水性樹脂用架橋剤および吸水性樹脂
JP2007262068A (ja) * 2006-03-28 2007-10-11 Epitech Group Srl 免疫系の一般的反応により引き起こされる病態の治療のための医薬組成物
JP2009545623A (ja) * 2006-08-04 2009-12-24 マリノメド・ビオテヒノロギー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング エスシンの使用
JP2012102097A (ja) * 2010-11-08 2012-05-31 Epitech Group Srl Ｎ−パルミトイル−バニルアミドを含有する局所使用用薬理学的製剤
JP2016028022A (ja) * 2014-07-08 2016-02-25 エピテック・グループ・ソチエタ・ア・レスポンサビリタ・リミタータＥＰＩＴＥＣＨ ＧＲＯＵＰ Ｓ．ｒ．ｌ． 上皮機能障害の処置におけるアデルミドロールの使用

Also Published As

Publication number Publication date
EP0550008A3 (en) 1994-12-07
CA2086441A1 (en) 1993-07-01
IT1252866B (it) 1995-06-28
ITMI913509A1 (it) 1993-07-01
ITMI913509A0 (it) 1991-12-31
EP0550008A2 (en) 1993-07-07

Similar Documents

Publication Publication Date Title
JPH05339153A (ja) アミノアルコールとポリカルボン酸とのｎ−アシル誘導体を含む医薬組成物
EP0550006B1 (en) Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
EP1378247B1 (en) Visual function disorder improving agents
EP1390365B1 (de) Neue sulfonat-substituierte pyrazolopyridinderivate
JPH07509247A (ja) ラパマイシン誘導体
JP7041673B2 (ja) Ｎ－アシルエタノールアミド誘導体およびその使用
JPH02500369A (ja) ３‐インドールピルビン酸誘導体およびそれらの医薬的使用
US5618842A (en) N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin
US10064853B2 (en) Compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomerase
KR20190039034A (ko) 특화된 사전 해소 매개체의 염에 관한 조성물 및 방법
US5750516A (en) Phosphoric diester
EP1900365B9 (en) Endocannabinoid-like compounds and their use for treating dermatitis
JPH06234756A (ja) スカベンジャー活性を有し、かつ過酸化および炎症症状を伴う急性および慢性病状に有用なヒドロキシアミンｎ−アシル誘導体
US20230312633A1 (en) Salts and polymorphs of cethromycin for the treatment of disease
CN101679416A (zh) 1－环丙基－6－氟代－7－(8－甲氧基亚氨基－2,6－二氮杂－螺环[3,4]辛－6－基)－4－氧代－1,4－二氢－[1,8]萘啶－3－羧酸的天冬氨酸盐、其制备方法、以及包含其的抗微生物药物组合物
EP0771564A1 (en) Interleukin-5 production inhibitor
EP0804179A2 (en) Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
WO2021138847A1 (en) Macrolide compound and its use of treatment chronic respiratory disease
JPH0278622A (ja) モノシアロガングリオシドのイソプロピルエステル誘導体の治療用途
CA2186243C (en) Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
US5244897A (en) Glycyl-p-amino-pyridine for the treatment of senile dementia states
CN111499619B (zh) 一种治疗肝纤维化的药物及其制备方法
EP4286385A1 (en) Novel maleate of triazolopyrazine derivative, composition, use method, and preparation method therefor
RU2697580C1 (ru) Новый цинковый комплекс, его получение и применение для терапии заболеваний человека и животных
WO2019114501A1 (zh) α-楝子素衍生物及其制备方法与应用